1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        North America Biodefense Market – By Product

1.3.2        North America Biodefense Market – By Country

2.           North America Biodefense Market – Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Biodefense Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        4.2.1 Biodefense Market - North America PEST Analysis

4.3         Expert Opinion

5.           North America Biodefense Market - Key Market Dynamics

5.1         Key Market Drivers

5.1.1        Presence of Favourable Government Initiatives

5.1.2        Increase in the Number of Naturally Occurring Outbreaks

5.2         Key Restraints

5.2.1        Limited Reach of Biodefense Organizations

5.3         Key Market Opportunities

5.3.1        Increasing Adoption of Technologies

5.4         Future Trend

5.4.1        Predictive Analytics to Reshape Biodefense Market

5.5         Impact Analysis

6.           Biodefense Market – North America Analysis

6.1         North America Biodefense Market Revenue Forecasts and Analysis

6.2         Market Positioning of Key Players

7.           North America Biodefense Market Analysis and Forecasts To 2027 – By Product Type

7.1         Overview

7.2         Biodefense Market Revenue Share, by Product (2019 and 2027)

7.1         Anthrax

7.1.1        Overview

7.1.2        Anthrax: Biodefense Market – Revenue and Forecast to 2027 (US$ Million)

7.2         Small pox

7.2.1        Overview

7.2.2        Small pox: Biodefense Market – Revenue and Forecast to 2027 (US$ Million)

7.3         Botulism

7.3.1        Overview

7.3.2        Botulism: Biodefense Market – Revenue and Forecast to 2027 (US$ Million)

7.4         Radiation/Nuclear

7.4.1        Overview

7.4.2        Radiation/Nuclear: Biodefense Market – Revenue and Forecast to 2027 (US$ Million)

7.5         Others

7.5.1        Overview

7.5.2        Others: Biodefense Market – Revenue and Forecast to 2027 (US$ Million)

8.           Biodefense Market Revenue and Forecasts To 2027 – Geographical Analysis

8.1         North America Biodefense Market Revenue and Forecasts To 2027

8.1.1        Overview

8.1.2        North America: Biodefense Market – Revenue and Forecast to 2027 (USD Million)

8.1.3        North America: Biodefense Market, by Product, 2018–2027 (USD Million)

8.1.4        North America: Biodefense Market, by Country, 2019 & 2027 (%)

8.1.5        US: Biodefense Market – Revenue and Forecast to 2027 (USD Million)

8.1.5.1          US: Biodefense Market – Revenue and Forecast to 2027 (USD Million)

8.1.5.2          US: Biodefense Market, by Product Type, 2018–2027 (USD Million)

8.1.6        Canada: Biodefense Market – Revenue and Forecast to 2027 (USD Million)

8.1.6.1          Canada: Biodefense Market – Revenue and Forecast to 2027 (USD Million)

8.1.6.2          Canada: Biodefense Market, by Product Type, 2018–2027 (USD Million)

8.1.7        Mexico: Biodefense Market – Revenue and Forecast to 2027 (USD Million)

8.1.7.1          Mexico: Biodefense Market – Revenue and Forecast to 2027 (USD Million)

8.1.7.2          Mexico: Biodefense Market, by Product Type, 2018–2027 (USD Million)

9.           North America Biodefense Market Industry Landscape

9.1         Overview

9.2         Growth Strategies in The Biodefense Market, 2016-2020

9.3         Inorganic Growth Strategies

9.3.1        Overview

9.4         Organic Growth Strategies

9.4.1        Overview

10.        COMPANY PROFILES

10.1      Bavarian Nordic

10.1.1     Key Facts

10.1.2     Business Description

10.1.3     Products and Services

10.1.4     Financial Overview

10.1.5     SWOT Analysis

10.1.6     Key Developments

10.2      Alnylam Pharmaceuticals, Inc.

10.2.1     Key Facts

10.2.2     Business Description

10.2.3     Products and Services

10.2.4     Financial Overview

10.2.5     SWOT Analysis

10.2.6     Key Developments

10.3      SIGA Technologies

10.3.1     Key Facts

10.3.2     Business Description

10.3.3     Products and Services

10.3.4     Financial Overview

10.3.5     SWOT Analysis

10.3.6     Key Developments

10.4      Emergent BioSolutions Inc.

10.4.1     Key Facts

10.4.2     Business Description

10.4.3     Products and Services

10.4.4     Financial Overview

10.4.5     SWOT Analysis

10.4.6     Key Developments

10.5      Cleveland Bio Labs

10.5.1     Key Facts

10.5.2     Business Description

10.5.3     Products and Services

10.5.4     Financial Overview

10.5.5     SWOT Analysis

10.5.6     Key Developments

10.6      Dynavax Technologies

10.6.1     Key Facts

10.6.2     Business Description

10.6.3     Products and Services

10.6.4     Financial Overview

10.6.5     SWOT Analysis

10.6.6     Key Developments

10.7      Elusys Therapeutics, Inc.

10.7.1     Key Facts

10.7.2     Business Description

10.7.3     Products and Services

10.7.4     Financial Overview

10.7.5     SWOT Analysis

10.7.6     Key Developments

10.8      Soligenix

10.8.1     Key Facts

10.8.2     Business Description

10.8.3     Products and Services

10.8.4     Financial Overview

10.8.5     SWOT Analysis

10.8.6     Key Developments

10.9      Altimmune

10.9.1     Key Facts

10.9.2     Business Description

10.9.3     Products and Services

10.9.4     Financial Overview

10.9.5     SWOT Analysis

10.9.6     Key Developments

10.10   Pluristem

10.10.1  Key Facts

10.10.2  Business Description

10.10.3  Products and Services

10.10.4  Financial Overview

10.10.5  SWOT Analysis

10.10.6  Key Developments

11.        Appendix

11.1      About The Insight Partners

11.2      Glossary of Terms

LIST OF TABLES

Table 1.             North America Biodefense Market, by Product– Revenue and Forecast to 2027  (USD Million)

Table 2.             US Biodefense Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 3.             Canada Biodefense Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 4.             Mexico Biodefense Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 5.             Recent Inorganic Growth Strategies In The Biodefense Market

Table 6.             Recent Organic Growth Strategies In The Biodefense Market

Table 7.             Glossary of Terms, Skin aesthetic devices market

LIST OF FIGURES

Figure 1.           Biodefense Market Segmentation

Figure 2.           North America Biodefense Market Overview

Figure 3.           Anthrax Segment Held Largest Share of Product Segment in Biodefense Market

Figure 4.           US Is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.           North America Biodefense Market- Leading Country Markets (US$ Mn)

Figure 6.           North America Biodefense Market, Industry Landscape

Figure 7.           Biodefense Market - North America PEST Analysis

Figure 8.           Biodefense Market Impact Analysis of Drivers and Restraints

Figure 9.           North America Biodefense Market – Revenue Forecasts and Analysis – 2019- 2027

Figure 10.        Market Positioning Of Key Players In Global Biodefense Market

Figure 11.        Biodefense Market Revenue Share, by Product (2019 and 2027)

Figure 12.        Anthrax: Biodefense Market – Revenue and Forecast to 2027 (US$ Million)

Figure 13.        Small pox: Biodefense Market – Revenue and Forecast to 2027 (US$ Million)

Figure 14.        Botulism: Biodefense Market – Revenue and Forecast to 2027 (US$ Million)

Figure 15.        Radiation/Nuclear: Biodefense Market – Revenue and Forecast to 2027 (US$ Million)

Figure 16.        Others: Biodefense Market – Revenue and Forecast to 2027 (US$ Million)

Figure 17.        North America: Biodefense Market, by Key Country – Revenue (2019) (USD Million)

Figure 18.        North America Biodefense Market Revenue and Forecast to 2027 (USD Million)

Figure 19.        North America: Biodefense Market, by Country, 2019 & 2027 (%)

Figure 20.        US: Biodefense Market – Revenue and Forecast to 2027 (USD Million)

Figure 21.        Canada: Biodefense Market – Revenue and Forecast to 2027 (USD Million)

Figure 22.        Mexico: Biodefense Market – Revenue and Forecast to 2027 (USD Million)

Figure 23.        Growth Strategies in the Biodefense Market, 2016-2020